Confounding and Mediation
Cross-source consensus on Confounding and Mediation from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Benefits
Evidence quality
Highlighted claims
- A directed acyclic graph was used to identify confounders and mediators between treatment and survival. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial
- Baseline confounders include age, comorbidities, lung function, performance status, hospital volume, and socioeconomic deprivation. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial
- Adjuvant treatment and postoperative toxicities are treated as mediators because they occur after treatment selection and may affect survival. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial
- DAGitty identified the same variables as the minimal sufficient adjustment set. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial
- Surgery may provide an advantage because invasive lymph node staging can reveal nodal metastasis and enable adjuvant chemotherapy. — Stereotactic ablative radiotherapy versus video-assisted lobectomy for operable stage I non-small-cell lung cancer: study protocol for an emulated target trial